Inhibiting the phosphatase activity of soluble epoxide hydrolase reduces arterial calcification and prevents the cardiovascular complications of chronic kidney disease

被引：0
|
作者：
Messaoudi, H. [1 ]
Varennes, O. [2 ]
Perzo, N. [1 ]
Berg, E. [1 ]
Levesque, T. [1 ,3 ]
Duflot, T. [1 ,4 ]
Chegrani, G. [1 ]
Kauffenstein, G. [5 ]
Dumesnil, A. [1 ]
Mulder, P. [1 ]
Brunel, V. [6 ]
Six, I. [2 ]
Mentaverri, R. [2 ]
Guerrot, D. [1 ,4 ]
Hamzaoui, M. [1 ,4 ]
Richard, V. [1 ,4 ]
Morisseau, C. [7 ,8 ]
Kamel, S. [2 ]
Proschak, E. [9 ]
Bellien, J. [1 ,4 ]
机构：
[1] Normandy Univ, UniRouen, FHU CARNAVAL, INSERM,UMR 1096,EnVI, F-76000 Rouen, France
[2] Univ Picardie Jules Verne, Ctr Rech Univ Sante, EA 7517, Mecanismes Physiopathol & Consequences Calcificat, Amiens, France
[3] Rouen Univ Hosp, Dept Cardiol, F-76000 Rouen, France
[4] Rouen Univ Hosp, Dept Pharmacol, F-76000 Rouen, France
[5] Strasbourg Univ, INSERM, UMR 1260, CRBS, Strasbourg, France
[6] Rouen Univ Hosp, Dept Gen Biochem, F-76000 Rouen, France
[7] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA
[8] Univ Calif Davis, UCD comprehens Canc Ctr, Davis, CA 95616 USA
[9] Goethe Univ, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷
关键词：
vascular calcification; phosphatase's soluble epoxide hydrolase; pyrophosphate; PPARg; chronic kidney disease;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CO-028
引用
收藏
页码：24 / 25
页数：2
相关论文
共 25 条
  • [21] Chronic Kidney Disease-Induced Arterial Media Calcification in Rats Prevented by Tissue Non-Specific Alkaline Phosphatase Substrate Supplementation Rather Than Inhibition of the Enzyme
    Opdebeeck, Britt
    Neven, Ellen
    Millan, Jose Luis
    Pinkerton, Anthony B.
    D'Haese, Patrick C.
    Verhulst, Anja
    PHARMACEUTICS, 2021, 13 (08)
  • [22] Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3-C5D chronic kidney disease
    Dzgoeva, Fatima U.
    Remizov, Oleg, V
    Goloeva, Victoria G.
    Ikoeva, Zarina R.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (06) : 468 - 474
  • [23] Vascular Effects of Advanced Glycation End-Products: Content of Immunohistochemically Detected AGEs in Radial Artery Samples as a Predictor for Arterial Calcification and Cardiovascular Risk in Asymptomatic Patients with Chronic Kidney Disease
    Janda, Katarzyna
    Krzanowski, Marcin
    Gajda, Mariusz
    Dumnicka, Paulina
    Jasek, Ewa
    Fedak, Danuta
    Pietrzycka, Agata
    Kuzniewski, Marek
    Litwin, Jan A.
    Sulowicz, Wladyslaw
    DISEASE MARKERS, 2015, 2015 : 1 - 9
  • [24] Addition of Endothelin A-Receptor Blockade Spoils the Beneficial Effect of Combined Renin-Angiotensin and Soluble Epoxide Hydrolase Inhibition: Studies on the Course of Chronic Kidney Disease in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats
    Certikova Chabova, Vera
    Kujal, Petr
    Vanourkova, Zdenka
    Skaroupkova, Petra
    Sadowski, Janusz
    Kompanowska-Jezierska, Elzbieta
    Tesar, Vladimir
    Hammock, Bruce
    Imig, John
    Maxova, Hana
    Cervenka, Ludek
    Vaneckova, Ivana
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (06): : 1493 - 1505
  • [25] Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease
    Chabova, Vera Certikova
    Kujal, Petr
    Skaroupkova, Petra
    Varnourkova, Zdenka
    Vackova, Sarka
    Huskova, Zuzana
    Kikerlova, Sona
    Sadowski, Janusz
    Kompanowska-Jezierska, Elzbieta
    Baranowska, Iwona
    Hwang, Sung Hee
    Hammock, Bruce D.
    Imig, John D.
    Tesar, Vladimir
    Cervenka, Ludek
    KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (02): : 329 - 349
123